cfDNA Extraction: Principles, Methods and Applications in Molecular Biology

AFFIGEN SCIENTIFIC BLOG

cfDNA Extraction

Explore the principles of cell-free DNA extraction, from sample collection and plasma preparation to DNA purification, quality control and advanced molecular research applications.

CELL-FREE DNA | LIQUID BIOPSY | MOLECULAR BIOLOGY

What Is Cell-Free DNA (cfDNA)?

Cell-free DNA (cfDNA) refers to extracellular DNA fragments that circulate in biological fluids, including blood plasma, serum and urine. These DNA fragments are released into the extracellular environment through biological processes such as apoptosis, necrosis and other forms of cellular activity.

In blood, circulating cfDNA originates from different tissues and cell populations. Its concentration, fragment size and molecular characteristics can vary depending on physiological conditions and disease-associated processes.

One important subset is circulating tumor DNA (ctDNA), which consists of DNA fragments released by tumor cells. Analysis of ctDNA can provide information about tumor-associated genetic alterations and is an important research area in liquid biopsy.

Why Is cfDNA Important?

cfDNA provides researchers with access to molecular information without requiring direct sampling of the tissue of origin. This makes it valuable for biomarker discovery, cancer research, prenatal research, transplantation studies and molecular diagnostics development.

Understanding cfDNA Characteristics

Before performing cfDNA extraction, it is important to understand the properties that distinguish cell-free DNA from conventional genomic DNA.

Fragmentation

cfDNA is generally fragmented rather than present as intact high-molecular-weight genomic DNA. Many circulating fragments are approximately nucleosomal in size, around 160-180 base pairs.

Low Concentration

Circulating cfDNA is often present at low concentrations, making sensitive extraction and quantification methods important for successful downstream analysis. 

Biological Origin

cfDNA originates from different cell populations. Its composition can reflect physiological processes, tissue turnover and disease-associated changes.

Sample Sensitivity

Improper sample handling can introduce genomic DNA released from blood cells, potentially affecting cfDNA measurements and downstream interpretation .

Common Sample Types for cfDNA Extraction

The selection of biological material depends on the research objective, target biomarkers and analytical method.

Blood Plasma

Plasma is widely preferred for circulating cfDNA and ctDNA analysis because it can reduce contamination from genomic DNA released during clot formation.

Blood Serum

Serum can be used in certain biomarker studies. However, clotting may cause the release of genomic DNA from blood cells, potentially increasing background DNA contamination.

Urine

Urinary cfDNA is investigated as a non-invasive source of molecular biomarkers, particularly in research involving urological diseases and other biological conditions.

The Main Steps of cfDNA Extraction

A successful cfDNA extraction workflow involves careful sample preparation, efficient DNA purification and appropriate quality assessment.

STEP 01

Sample Collection

The first stage involves collecting an appropriate biological sample. For circulating cfDNA studies, peripheral blood is commonly collected using suitable EDTA tubes or specialized cfDNA stabilization tubes.

Sample collection conditions are important because delays in processing and improper handling can lead to blood cell disruption and contamination with genomic DNA.

Key consideration: Select appropriate collection tubes and maintain standardized handling conditions.

STEP 02

Plasma Separation

For blood-based cfDNA analysis, plasma is generally separated from blood cells through centrifugation. A two-step centrifugation workflow is commonly used to remove cellular material, residual platelets and debris.

After centrifugation, the plasma supernatant is carefully transferred into a clean tube without disturbing the buffy coat or cellular fraction.

Key consideration: Minimize cellular contamination to preserve the original cfDNA profile.

STEP 03

Cell-Free DNA Extraction

The prepared plasma is processed using a dedicated cfDNA purification method. Depending on the extraction system, DNA fragments are captured using silica-based membranes, magnetic silica beads or other nucleic acid binding technologies.

Extraction chemistry is designed to recover low-abundance, fragmented DNA while reducing proteins, salts and other sample contaminants.

Key consideration: Select an extraction method suitable for short DNA fragments and the required sample input volume.

STEP 04

DNA Purification and Washing

During purification, the captured DNA is separated from unwanted substances through washing steps. These steps help remove proteins, residual salts, inhibitors and other contaminants that could interfere with subsequent molecular assays.

The precise washing conditions depend on the extraction chemistry and the manufacturer's validated protocol.

Key consideration: Maintain efficient purification while minimizing the loss of short DNA fragments.

STEP 05

DNA Elution

Following purification, the retained DNA is released from the binding matrix using an appropriate elution solution or buffer.

The purified cfDNA is collected in a clean tube and can be used for downstream molecular biology applications or stored under validated conditions.

Key consideration: Choose an appropriate elution volume according to the desired DNA concentration and downstream application.

STEP 06

Quality Control and Quantification

After extraction, the purified cfDNA should be evaluated to determine its concentration, fragment distribution and suitability for downstream analysis.

Fluorometric assays, quantitative PCR (qPCR), digital PCR (dPCR) and electrophoretic fragment analysis can provide complementary information about DNA quantity and quality.

Key consideration: Use quality assessment methods appropriate for low-concentration and fragmented DNA.

Common cfDNA Extraction Methods

Different extraction technologies are available for isolating circulating DNA. The choice depends on sample volume, expected DNA concentration, fragment size, laboratory throughput and downstream applications.

1. Silica-Based Spin Columns

This approach uses a silica membrane to bind DNA under appropriate chemical conditions. Contaminants are removed through washing, and purified DNA is recovered through elution.

Advantages:

Established purification workflow and convenient manual processing.

2. Magnetic Bead-Based Extraction

Magnetic silica particles capture DNA fragments under suitable binding conditions. Magnetic separation allows washing and purification before DNA elution.

Advantages:

Supports automation, scalable workflows and high-throughput processing.

3. Automated Extraction Systems

Automated platforms can use magnetic particle-based purification to standardize sample processing and reduce manual handling.

Advantages:

Improved workflow consistency, reproducibility and laboratory throughput when properly validated.

How to Evaluate cfDNA Extraction Quality

Because circulating cfDNA is often present at low concentrations, assessing extraction performance requires appropriate analytical techniques.

Quality Parameter Analytical Method Purpose
DNA Concentration Fluorometry Estimate DNA quantity
Target DNA Quantity qPCR / dPCR Quantify specific DNA targets
Fragment Distribution Capillary Electrophoresis Assess DNA fragment sizes
DNA Purity Spectrophotometry Assess potential contaminants, with limitations at low concentrations
Important:

No single quality control method provides a complete picture of cfDNA extraction performance. Combining concentration measurements with fragment analysis and target-specific molecular assays can provide more informative results.

Applications of cfDNA Extraction in Research

Purified cfDNA can support a wide range of molecular biology and biomedical research applications.

Liquid Biopsy Research

Investigation of circulating tumor-associated DNA alterations using minimally invasive biological samples.

Cancer Research

Study of tumor-associated mutations, molecular biomarkers and genetic changes during disease progression.

Prenatal Research

Analysis of cell-free fetal DNA in maternal plasma for non-invasive prenatal testing research.

Transplantation Research

Investigation of donor-derived cell-free DNA as a potential biomarker in transplantation studies.

Next-Generation Sequencing

Preparation of cfDNA samples for sequencing-based analysis of genetic variations and molecular profiles.

Biomarker Discovery

Exploration of DNA-based biomarkers for disease research and molecular characterization.

Common Challenges in cfDNA Extraction

Several technical factors can affect cfDNA recovery, fragment integrity and analytical performance.

Challenge Recommended Consideration
Low DNA Recovery Evaluate extraction chemistry, sample input and recovery of short DNA fragments.
Genomic DNA Contamination Optimize sample handling and plasma separation procedures.
DNA Fragment Loss Choose purification systems designed to retain relevant short DNA fragments.
Sample Degradation Use validated storage conditions and minimize repeated freeze-thaw cycles.
Inconsistent Results Standardize sample collection, processing, extraction and quality control.

Best Practices for cfDNA Storage and Handling

Proper storage and sample handling are essential for preserving cfDNA integrity and maintaining reproducible analytical results.

  • Use appropriate blood collection and cfDNA stabilization tubes.
  • Follow validated plasma separation procedures.
  • Avoid disturbing the cellular layer during plasma transfer.
  • Use clean, low-binding tubes when appropriate.
  • Store plasma or purified cfDNA under validated temperature conditions.
  • Prepare aliquots to reduce repeated freeze-thaw cycles.
  • Document sample processing and storage conditions.

Storage duration and temperature should be validated for the sample type, extraction workflow and downstream application.

AFFIGEN | MOLECULAR BIOLOGY

Support Your Molecular Biology Research

Explore Affigen's scientific research solutions and discover laboratory products designed to support molecular biology workflows, nucleic acid research and advanced biomarker studies.

EXPLORE AFFIGEN

Frequently Asked Questions About cfDNA Extraction

1. What is cfDNA extraction?

cfDNA extraction is the process of isolating extracellular DNA fragments from biological samples such as plasma, serum or urine for molecular analysis.

2. Why is plasma preferred for circulating cfDNA analysis?

Plasma is generally preferred because serum preparation can release additional genomic DNA from blood cells during clot formation, potentially affecting cfDNA measurements.

3. What is the difference between cfDNA and ctDNA?

cfDNA refers to all extracellular DNA fragments circulating in biological fluids, whereas ctDNA is the tumor-derived fraction of circulating cfDNA.

4. Which methods are used for cfDNA extraction?

Common methods include silica-based spin columns, magnetic bead-based purification and automated nucleic acid extraction platforms.

5. How is cfDNA concentration measured?

Fluorometry, quantitative PCR and digital PCR can be used to evaluate cfDNA quantity. The most appropriate method depends on the analytical objective.

6. What are the main applications of cfDNA extraction?

Applications include liquid biopsy research, cancer biomarker studies, prenatal research, transplantation research and next-generation sequencing.

Scientific References and Further Reading

For additional scientific information about cfDNA extraction, sample preparation and analytical methods:

  1. Peng H. et al. (2024). The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples. Frontiers in Cell and Developmental Biology. Read publication.
  2. Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays. Read publication.
  3. National Cancer Institute. Cell-Free DNA: Biospecimen Collection and Processing. View guidelines.
  4. Terp S.K. et al. (2024). Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality. The Journal of Molecular Diagnostics. Read publication.

Advancing scientific knowledge through molecular biology research.

© Affigen | Scientific Research Solutions

www.affigen.com
16th Nov 2026

Recent Posts